Brazil may be struggling in its battle against the coronavirus, but it is on the cutting edge of vaccine development with large-scale trials and the production of millions of doses on the horizon. Phase Three tests for the vaccine began in June in Brazil, as well as in the UK and South Africa. If the vaccine passes the clinical trials, Brazil will be entitled to produce 70 million additional doses at an estimated cost of $2.30 each. "We will have the autonomy necessary to meet the demand from Brazil, but also other Latin American countries," he said. With the two large-scale trials, "Brazil is the repository for the hopes of a large part of the world," Covas added.

Source: News 24 July 07, 2020 18:43 UTC